Oleptiss 90mg Tablet DT
By Oleptiss
Rx
10 Tablet DT in a Strip

Composition
Deferasirox(90mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
August, 2025

liver
When using Oleptiss 90mg Tablet DT, it is important to be cautious if you have liver disease. Patients with liver issues might require a dose adjustment while taking this medication. It is advised to consult your doctor before using Oleptiss 90mg Tablet DT if you have liver disease, as there is limited information available about its use in patients with liver conditions.

kidney
Oleptiss 90mg Tablet DT may not be safe for patients with kidney disease and should be avoided. Please consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Oleptiss 90mg Tablet DT.

driving
When using Oleptiss 90mg Tablet DT, be cautious as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Oleptiss 90mg Tablet DT may not be safe during pregnancy. Animal studies suggest possible harm to the developing baby. Consult your doctor for a careful evaluation of benefits and risks before using this medication.

breastfeeding
Oleptiss 90mg Tablet DT is considered safe for breastfeeding moms. Limited data shows it poses minimal risk to the baby.
Habit Forming | No |
Chemical Class | Triazole & benzoate derivative |
Therapeutic Class | - |
Action Class | Iron chelating agents |
₹752
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025